Rivaroxaban ist bei Malignom-assoziierten Thrombembolien nicht unterlegen.

IF 2.7 4区医学 Q2 HEMATOLOGY

Hamostaseologie Pub Date : 2024-08-01 Epub Date: 2024-08-16 DOI:10.1055/s-0044-1789284

引用次数: 0

查看原文本刊更多论文

利伐沙班治疗恶性肿瘤相关血栓栓塞症的效果并不差。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hamostaseologie HEMATOLOGY-

CiteScore

5.50

自引率

6.20%

发文量

审稿时长

6-12 weeks

期刊介绍： Hämostaseologie is an interdisciplinary specialist journal on the complex topics of haemorrhages and thromboembolism and is aimed not only at haematologists, but also at a wide range of specialists from clinic and practice. The readership consequently includes both specialists for internal medicine as well as for surgical diseases.